Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients.
OBJECTIVES:There is limited information on the epidemiology and treatment patterns of rheumatoid arthritis (RA) across the Arab region. We aim in this study to describe the demographic characteristics, clinical profile, and treatment patterns of patients of Arab ancestry with RA. METHODS:This is a c...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0208240 |
id |
doaj-85481b56a84e411b8fb5e9f301919d79 |
---|---|
record_format |
Article |
spelling |
doaj-85481b56a84e411b8fb5e9f301919d792021-03-03T21:01:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011312e020824010.1371/journal.pone.0208240Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients.Soha R DarghamSumeja ZahirovicMohammed HammoudehSamar Al EmadiBasel K MasriHussein HalabiHumeira BadshaImad UthmanZiyad R MahfoudHadil AshourWissam Gad El HaqKarim BayoumyMarianthi KapiriRicha SaxenaRobert M PlengeLayla KazkazThurayya ArayssiOBJECTIVES:There is limited information on the epidemiology and treatment patterns of rheumatoid arthritis (RA) across the Arab region. We aim in this study to describe the demographic characteristics, clinical profile, and treatment patterns of patients of Arab ancestry with RA. METHODS:This is a cross sectional study of 895 patients with established rheumatoid arthritis enrolled from five sites (Jordan, Lebanon, Qatar, Kingdom of Saudi Arabia (KSA), and United Arab Emirates). Demographic characteristics, clinical profile, and treatment patterns are compared between the five countries. RESULTS:The majority of our patients are women, have an average disease duration of 10 years, are married and non-smokers, with completed secondary education. We report a high (>80%) ever-use of methotrexate (MTX) and steroids among our RA population, while the ever-use of disease modifying anti-rheumatic drugs (DMARDs) and TNF-inhibitors average around 67% and 33%, respectively. There are variations in RA treatment use between the five country sites. Highest utilization of steroids is identified in Jordan and KSA (p-value < 0.001), while the highest ever-use of TNF-inhibitors is reported in KSA (p-value < 0.001). CONCLUSION:Disparities in usage of RA treatments among Arab patients are noted across the five countries. National gross domestic product (GDP), as well as some other unique features in each country likely affect these. Developing treatment guidelines specific to this region could contribute in delivering standardized therapies to RA patients.https://doi.org/10.1371/journal.pone.0208240 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Soha R Dargham Sumeja Zahirovic Mohammed Hammoudeh Samar Al Emadi Basel K Masri Hussein Halabi Humeira Badsha Imad Uthman Ziyad R Mahfoud Hadil Ashour Wissam Gad El Haq Karim Bayoumy Marianthi Kapiri Richa Saxena Robert M Plenge Layla Kazkaz Thurayya Arayssi |
spellingShingle |
Soha R Dargham Sumeja Zahirovic Mohammed Hammoudeh Samar Al Emadi Basel K Masri Hussein Halabi Humeira Badsha Imad Uthman Ziyad R Mahfoud Hadil Ashour Wissam Gad El Haq Karim Bayoumy Marianthi Kapiri Richa Saxena Robert M Plenge Layla Kazkaz Thurayya Arayssi Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients. PLoS ONE |
author_facet |
Soha R Dargham Sumeja Zahirovic Mohammed Hammoudeh Samar Al Emadi Basel K Masri Hussein Halabi Humeira Badsha Imad Uthman Ziyad R Mahfoud Hadil Ashour Wissam Gad El Haq Karim Bayoumy Marianthi Kapiri Richa Saxena Robert M Plenge Layla Kazkaz Thurayya Arayssi |
author_sort |
Soha R Dargham |
title |
Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients. |
title_short |
Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients. |
title_full |
Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients. |
title_fullStr |
Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients. |
title_full_unstemmed |
Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients. |
title_sort |
epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of arab patients. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2018-01-01 |
description |
OBJECTIVES:There is limited information on the epidemiology and treatment patterns of rheumatoid arthritis (RA) across the Arab region. We aim in this study to describe the demographic characteristics, clinical profile, and treatment patterns of patients of Arab ancestry with RA. METHODS:This is a cross sectional study of 895 patients with established rheumatoid arthritis enrolled from five sites (Jordan, Lebanon, Qatar, Kingdom of Saudi Arabia (KSA), and United Arab Emirates). Demographic characteristics, clinical profile, and treatment patterns are compared between the five countries. RESULTS:The majority of our patients are women, have an average disease duration of 10 years, are married and non-smokers, with completed secondary education. We report a high (>80%) ever-use of methotrexate (MTX) and steroids among our RA population, while the ever-use of disease modifying anti-rheumatic drugs (DMARDs) and TNF-inhibitors average around 67% and 33%, respectively. There are variations in RA treatment use between the five country sites. Highest utilization of steroids is identified in Jordan and KSA (p-value < 0.001), while the highest ever-use of TNF-inhibitors is reported in KSA (p-value < 0.001). CONCLUSION:Disparities in usage of RA treatments among Arab patients are noted across the five countries. National gross domestic product (GDP), as well as some other unique features in each country likely affect these. Developing treatment guidelines specific to this region could contribute in delivering standardized therapies to RA patients. |
url |
https://doi.org/10.1371/journal.pone.0208240 |
work_keys_str_mv |
AT sohardargham epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT sumejazahirovic epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT mohammedhammoudeh epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT samaralemadi epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT baselkmasri epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT husseinhalabi epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT humeirabadsha epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT imaduthman epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT ziyadrmahfoud epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT hadilashour epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT wissamgadelhaq epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT karimbayoumy epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT marianthikapiri epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT richasaxena epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT robertmplenge epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT laylakazkaz epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients AT thurayyaarayssi epidemiologyandtreatmentpatternsofrheumatoidarthritisinalargecohortofarabpatients |
_version_ |
1714819171142860800 |